|
PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System) |
1R44HL165972-01 |
|
NHLBI |
2022 |
|
PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 2 |
1R44HL166048-01 |
|
NHLBI |
2022 |
|
RNA Toxicity and Cardiac Pathology |
1R56HL162953-01 |
|
NHLBI |
2022 |
|
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial |
1R61HL155858-01A1 |
|
NHLBI |
2022 |
|
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease |
1R61HL156152-01A1 |
|
NHLBI |
2022 |
|
Broad Bandwidth Transducers for High Resolution Information Rich IVUS |
1R61HL156154-01A1 |
|
NHLBI |
2022 |
|
Home sleep apnea testing compared to in-lab polysomnography for the evaluation of obstructive sleep apnea in children |
1R61HL162839-01 |
|
NHLBI |
2022 |
|
Treatment of Obstructive Sleep Apnea with Personalized Surgery in Children with Down Syndrome (TOPS-DS) |
1R61HL165345-01 |
|
NHLBI |
2022 |
|
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea |
1R61HL165366-01 |
|
NHLBI |
2022 |
|
The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation. |
1U01HL163242-01 |
|
NHLBI |
2022 |